Table 1.

Patient characteristics

Study no.AgeSexRaceTreatmentcTNMpTNMSiteGradeRFS (mo)StatusDeath cause
MD8E374MN/AN/AT3N2bM0T3N2bM0OCPoorN/AN/ADOD
VA29147MWs→xrt/chemoT3N2bM0T3N2bM0OPModerate10NEDDOC
VA42456MWs→xrtT4N2bM0T4N2bM0OPModerate72NEDAlive
VU11944MWs→xrtT1N2bM0T1N2bM0OPModerate105NEDAlive
VU15060MBs→xrtT2N2bM0T2N2bM0OPModerate81NEDDOC
VU26558MWs→xrtT2N2bM0T2N2bM0OCModerate86NEDAlive
VU28347MWs→xrt/chemoT2N2aM0T2N2aM0OPModerate58NEDAlive
VU28463MWs→xrt/chemoT4N1M0T4N1M0OPModerate12NEDDOC
VU28560MWs→xrtT1N2bM0T1N2bM0OCPoor83NEDAlive
VU30014850MWs onlyT3N0M0T3N0M0LModerate28NEDAlive
VU30024977MHi→ccr→sT3N3M0N/AOPModerate25NEDAlive
VU3641FWs→xrt/chemoT1N2cM0T1N2cM0LWell38NEDDOC
VU5355MWs→xrtT3N0M0T3N0M0LModerate77NEDDOC
VU30063769MWs→xrt/chemoT2N1M0T1N1M0OCWell10NEDAlive
VU3011161MWs→xrtT1N1M0T4N0M0OCModerate5NEDAlive
VA24852MBs→xrtT2N1M0T2N1M0OPModerate4RECDOD
VA41854MWs→xrtT2N2aT4N2bM0OPModerate70RECAlive
VA43557MWs→xrt/chemoT3N2cM0T3N2cM0OCModerate22RECDOD
VU1370357MWs→xrtT3N0M0T2N2bM0OCWell21RECAlive
VU64053MWs→xrt/chemoT3N1M0T2N2bM0OCModerate9RECAlive
VU13258MWs→xrt/chemoT4N2bM0T2N2bM0OCModerate8RECDOD
VU29178MWs onlyT2N0M0T2N0M0OPModerate6RECDOC
VU30066347FWs onlyT2N0M0T2N0M0OCModerate14RECAlive
VU601874MWs onlyT2N0M0T2N0M0OCModerate25RECAlive
VU1795641MOs→xrtT2N0M0T2N1M0OCModerate6RECAlive
MD147E581MWs→xrtT4N2aM0T4N2aM0LModerate13RECDOD
MD337H856MWs→xrtT4N2cM0T4N0M0OCModerate18RECDOD
VU23280MWs→xrt/chemoT4N1M0T4N2cM0LModerate27RECDOD
VU26055MWs→xrt/chemoT2N3M0T2N3M0OPModerate16RECDOC
  • Abbreviations: cTNM, clinical TNM; pTNM, pathologic TNM; s, surgery; xrt, radiation therapy; xrt/chemo, concurrent chemoradiation therapy; i→ccr→s, induction chemotherapy followed by concurrent chemoradiation therapy and salvage surgery; OC, oral cavity; OP, oropharynx; L, larynx; NED, no evidence of disease; REC, recurrence; DOC, died of other cause; DOD, died of disease.